Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Cel-Sci (CVM) has a market cap of $30.139 million USD. According to our data, Cel-Sci is ranked No.8414 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $30.14 M |
1.67%
|
| Dec 31, 2024 | $29.64 M |
-85.29%
|
| Dec 29, 2023 | $0.20 B |
15.74%
|
| Dec 30, 2022 | $0.17 B |
-66.90%
|
| Dec 31, 2021 | $0.53 B |
-39.11%
|
| Dec 31, 2020 | $0.86 B |
27.43%
|
| Dec 31, 2019 | $0.68 B |
218.82%
|
| Dec 31, 2018 | $0.21 B |
51.85%
|
| Dec 29, 2017 | $0.14 B |
8.00%
|
| Dec 30, 2016 | $0.13 B |
-81.08%
|
| Dec 31, 2015 | $0.69 B |
-36.21%
|
| Dec 31, 2014 | $1.07 B |
-1.69%
|
| Dec 31, 2013 | $1.09 B |
-78.15%
|
| Dec 31, 2012 | $5.00 B |
-6.90%
|
| Dec 30, 2011 | $5.37 B |
-64.63%
|
| Dec 31, 2010 | $15.19 B |
-8.89%
|
| Dec 31, 2009 | $16.67 B |
210.34%
|
| Dec 31, 2008 | $5.37 B |
-43.14%
|
| Dec 31, 2007 | $9.45 B |
-8.93%
|
| Dec 29, 2006 | $10.37 B |
14.29%
|
| Dec 30, 2005 | $9.08 B |
-18.33%
|
| Dec 31, 2004 | $11.12 B |
-43.40%
|
| Dec 31, 2003 | $19.64 B |
404.76%
|
| Dec 31, 2002 | $3.89 B |
-77.89%
|
| Dec 31, 2001 | $17.60 B |
-36.67%
|
| Dec 29, 2000 | $27.79 B |
-35.14%
|
| Dec 31, 1999 | $42.84 B |
32.14%
|
| Dec 31, 1998 | $32.42 B |
-73.58%
|
| Dec 31, 1997 | $122.74 B |
55.88%
|
| Dec 31, 1996 | $78.74 B |
18.26%
|
| Dec 29, 1995 | $66.58 B |
-11.54%
|
| Dec 30, 1994 | $75.26 B |
-71.74%
|
| Dec 31, 1993 | $266.32 B |
-24.59%
|
| Dec 31, 1992 | $353.17 B |
-40.20%
|
| Dec 31, 1991 | $590.54 B |
410.00%
|
| Dec 31, 1990 | $115.79 B |
25.00%
|
| Dec 29, 1989 | $92.63 B |
-20.00%
|
| Dec 30, 1988 | $115.79 B |
-73.68%
|
| Dec 31, 1987 | $440.01 B |
-38.71%
|
| Dec 31, 1986 | $717.91 B |
121.43%
|
| Dec 31, 1985 | $324.22 B |
180.00%
|
| Dec 31, 1984 | $115.79 B |
-28.57%
|
| Dec 30, 1983 | $162.11 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
 BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
 Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
 AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
| Market Cap | = | CVM Stock Price | * | CVM Shares Outstanding |
| = | $0.41 | * | 74.11 M | |
| = | $30.14 M |